REQUEST A DEMO
Total
USD $0.00
Search more companies

Dermedica Medical S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Dermedica Medical S.A.S. Profile Updated: April 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Dermedica Medical S.A.S. is an enterprise in Colombia, with the main office in Bogota D.C.. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was incorporated on September 13, 2022. The total number of employees is currently 15 (2025). The company’s latest financial report indicates a net sales revenue increase of 75.84% in 2024. Its’ total assets recorded a growth of 21.97%. Dermedica Medical S.A.S.’s net profit margin decreased by 3.13% in 2024.

Headquarters
Transversal 19 A # 98 - 28
Bogota D.C.; Bogota D.C; Postal Code: 0814

Contact Details: Purchase the Dermedica Medical S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Dermedica Medical S.A.S. report to view the information.
Financial Auditors:
Purchase the Dermedica Medical S.A.S. report to view the information.
Incorporation Date:
September 13, 2022
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Fiscal Inspector
Ownership Details
Purchase this report to view the information.
Subsidiaries
Dermedica Medical S.A.S.
Company Performance
Financial values in the chart are available after Dermedica Medical S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
75.84%
Total operating revenue
75.84%
Operating profit (EBIT)
-89.79%
Net Profit (Loss) for the Period
-121.98%
Total Assets
21.97%
Total Equity
-132.81%
Operating Profit Margin (ROS)
-0.88%
Net Profit Margin
-3.13%
Return on Equity (ROE)
-2.74%
Quick Ratio
1.3%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?